You just read:

VistaGen and Baylor College of Medicine Announce Successful Results of First-Step Target Engagement Study with VistaGen's AV-101 Focused on Treating Suicidal Ideation in Veterans

News provided by

VistaGen Therapeutics

Dec 19, 2019, 08:30 ET